Cargando…
Pigment Epithelium-Derived Factor-Loaded PEGylated Nanoparticles as a New Antiangiogenic Therapy for Neovascularization
BACKGROUND: Pathological neovascularization, which involves a disruption in the balance between angiogenic and antiangiogenic factors under pathological conditions, is the basis of many intraocular diseases. Pigment epithelium-derived factor (PEDF) is a potent natural, endogenous inhibitor of neovas...
Autores principales: | Zhao, Feng, Fei, Wenlei, Li, Zhouyue, Yu, Hanyang, Xi, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9054434/ https://www.ncbi.nlm.nih.gov/pubmed/35493608 http://dx.doi.org/10.1155/2022/1193760 |
Ejemplares similares
-
Pigment Epithelium-Derived Factor as a Possible Treatment Agent for Choroidal Neovascularization
por: Xi, Lei
Publicado: (2020) -
Molecular phylogeny of the antiangiogenic and neurotrophic serpin, pigment epithelium derived factor in vertebrates
por: Xu, Xuming, et al.
Publicado: (2006) -
Progression of Retinal Pigment Epithelial Atrophy in Antiangiogenic Therapy of Neovascular Age-Related Macular Degeneration
por: Schütze, Christopher, et al.
Publicado: (2015) -
Anti-inflammatory properties of antiangiogenic fucoidan in retinal pigment epithelium cells
por: Dörschmann, Philipp, et al.
Publicado: (2023) -
Role of Pigment Epithelium-Derived Factor in Stem/Progenitor Cell-Associated Neovascularization
por: Liu, Jung-Tung, et al.
Publicado: (2012)